Cere` et al.
preparative HPLC, was obtained as a pale yellow deliquescent
1
solid. H NMR (300 MHz, CDCl3) δ 4.20 (dd, 2H, J ) 1.9, 5.9
Hz), 4.05 (br t, 2H, J ) 6.0-8.0 Hz), 3.05 (br s, 2H, 2OH),
2.89 (d, 2H, J ) 14.2 Hz), 2.57 (dd, 2H, J ) 8.54, 14.4 Hz),
1.50 (s, 3H), 1.39 (s, 3H); 13C NMR (75 MHz, CDCl3) δ108.6
(C), 80.8 (2CHO), 73.3 (2CHO), 33.4 (2CH2S), 27.2 (CH3), 24.4
(CH3); IR (KBr) (cm-1) 3368, 2974, 2909, 1377, 1208, 1091,
1045, 896; ESI-MS 221 (MH+). Anal. Calcd for C9H16O4S: C,
49.07; H, 7.32. Found: C, 49.06; H, 7.30.
(3R,4S,5R,6S)-3,6-Dihydroxy-4,5-O-isopropylidene-thi-
epane (6, meso form). The title compound, isolated by
preparative HPLC, was obtained as a white crystalline product
(mp 176 °C). 1H NMR (300 MHz, CDCl3) δ 4.35 (br s, 2H), 4.14
(t, 2H, J ) 8.1 Hz), 3.35 (d, 2H, 2OH, J ) 8.2 Hz), 2.97 (dd,
2H, J ) 8.5, 14.7 Hz), 2.61 (d, 2H, J ) 14.7 Hz), 1.58 (s, 3H),
1.39 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 108.8 (C), 79.5
(CHO), 70.6 (CHO), 33.0 (CH2S), 26.1 (CH3), 23.8. (CH3); IR
(KBr) (cm-1) 3333, 2936, 1421, 1250, 1184, 1013, 909; m/z 59
(100), 71 (50), 89 (25), 101 (41), 161 (39), 202 (38), 205 (33),
220 (10). Anal. Calcd for C9H16O4S: C, 49.07; H, 7.32. Found:
C, 49.00; H, 7.29.
Compounds (()-2,19 (-)-4,20 and (()-519 have spectroscopic
data in agreement with those reported in the literature.
Compound (+)-4 {[R]25 +36.2 (c 1.0 in CHCl3)} has spectro-
D
scopic data in perfect agreement with those of the correspond-
ing enantiomer (-)-4.
(+)-(3R,4S,5R,6R)-3,6-Dihydroxy-4,5-O-isopropylidene-
thiepane ((+)-3). The title compound, enantiomerically pure
after enantioselective HPLC separation, was obtained as a
white solid (mp 119-120 °C). 1H NMR (300 MHz, acetone-d6)
δ 4.38 (m, 1H, CHO), 4.20 (m, 3H, 1CHO and 2OH), 3.87 (m,
2H, 2CHO), 3.03-2.42 (m, 4H, 2CH2), 1.43 (s, 3H, CH3), 1.28
(s, 3H, CH3); 13C NMR (75 MHz, acetone-d6) δ 108.2 (C), 81.3
(CHO), 80.3 (CHO), 72.7 (CHO), 72.3 (CHO), 33.7 (CH2), 33.3
(CH2), 26.8 (CH3), 24.2 (CH3); IR (KBr) (cm-1) 3288, 2986, 2917,
1383, 1259, 1211, 1166, 1085, 1057, 1007, 893; [R]25D +9.76 (c
1.0 in CHCl3, ee >99%); m/z 59 (100), 71 (52), 89 (26), 101 (41),
161 (40), 202 (38), 205 (32), 220 (13). Anal. Calcd for
C9H16O4S: C, 49.09; H, 7.34. Found: C, 49.11; H, 7.34.
Chromatographic Procedures. For the analytical HPLC
experiments the following equipment was used: pump Waters
600E, Refractive Index detector Waters R401, UV detector
Waters 448, Rheodyne 20 µL loop injector. Preparative separa-
tions: pump Waters Delta Prep 3000, RI detector Waters 410,
Rheodyne 0.5 mL loop injector. Preparative separations:
samples were dissolved in the mobile phase at a concentration
of about 0.1 g/mL and injected through a 0.5 mL loop.
Vibrational Circular Dichroism Spectroscopy and
DFT Calculations. IR and VCD spectra of 3 were measured
in CHCl3 solution. IR spectra were measured using a Nicolet
MX-1 FTIR instrument at 1 cm-1 resolution. VCD spectra were
measured using a Bomem/BioTools ChiralIR spectrometer at
4 cm-1 resolution. VCD data acquisition times were 1 h.
Solutions of (+)- and (-)-3 were ∼0.06 M. Enantiomeric
excesses of (+)- and (-)-3 were >99% and >95%, respectively.
Solutions of (()-3 of comparable concentration were used to
obtain VCD baselines. VCD spectra are reported as “half-
difference” spectra: 1/2[∆ꢀ(+) - ∆ꢀ(-)].
FIGURE 5. Calculated and experimental VCD spectra of 3.
The calculated spectra (3R,4S,5R,6R)-3 and (3S,4R,5S,6S)-3
are the conformationally averaged B3LYP/TZ2P spectra for
the (3R,4S,5R,6R) and (3S,4R,5S,6S) enantiomers of 3. The
experimental spectrum is from Figure 3. Numbers indicate
corresponding features in the calculated spectrum (3R,4S,
5R,6R)-3 and the experimental spectrum of (+)-3.
2H), 3.18-2.88 (m, 2H), 2.83-2.56 (m, 4H), 1.45-1.23 (ss, 6H);
13C NMR (75 MHz,CDCl3) δ 110.5, 110.3, 110.1, 109.9, 80.1,
78.3, 78.1, 77.6, 51.5, 51.3, 51.1, 50.2, 49.6, 49.4, 46.4, 45.9,
45.5, 44.1, 43.7, 43.6, 43.5, 43.3, 29.2, 28.7, 27.4, 27.1, 26.9,
26.8, 26.6, 26.5, 25.1, 24.9.
2,2-Dimethylhexahydrothiepino[4,5-d][1,3]dioxole-4,8-
diol (mix-4). Following a literature procedure,18 to 400 mL
of EtOH, refluxing under nitrogen, was added 4.5 g of Na2S‚
9H2O (18.7 mmol) dissolved in 75 mL of EtOH. To this
refluxing solution was simultaneously added dropwise 2.4 g
(12.9 mmol) of the dioxiranyl derivative mix-3 dissolved in
150 mL of EtOH and 4.5 g of Na2S‚9H2O (18.7 mmol) dissolved
in 75 mL of EtOH. After 48 h refluxing, the crude product,
obtained from evaporation of the solvent, was extracted
repeatedly with CH2Cl2. The dried organic layer was purified
by flash chromatography (SiO2; Et2O) yielding 1.64 g (57.8%)
of a mixture with the diastereoisomeric ratio of the crude
product. 1H NMR (300 MHz, CDCl3) δ 4.30-3.75 (m, 4H), 3.32
(br s, 2H), 3.00-2.38 (m, 4H), 1.45-1.22 (ss superimposed 6H);
13C NMR (75 MHz, CDCl3) δ 109.4, 109.1, 108.8, 108.6, 108.0,
81.4, 80.7, 79.8, 79.1, 78.7, 78.6, 75.9, 73.9, 73.2, 71.6, 70.9,
66.2, 66.0, 38.1, 38.0, 37.6, 37.2, 33.5, 33.0, 32.8, 32.5, 27.2,
27.0, 26.9, 26.7, 26.4, 26.0, 23.8.
Conformational analysis of 3 was carried out using the
Spartan 0221 and Gaussian 9822 programs, using the following
protocol. A Monte Carlo conformational search was initially
carried out using the MMFF94 molecular mechanics force field
via the Spartan 02 program. All structures found within a 10
kcal/mol window were reoptimized, first using the AM1
semiempirical method and then using the Hartree-Fock (HF)/
6-31G* ab initio method. Finally, all structures within a 3.0
kcal/mol window at the HF/6-31G* level were reoptimized
using Density Functional Theory (DFT), the functionals
(3R,4R,5S,6S)-3,6-Dihydroxy-4,5-O-isopropylidene-thi-
epane (1, meso form). The title compound, isolated by
(19) Kuszmann, J.; Soha`r, P. Carbohydr. Res. 1977, 56, 105-115.
(20) Kuszmann, J.; Soha`r, P.; Horva`th, G. Carbohydr. Res. 1976,
50, 45-52
(18) Fuzier, M.; LeMerrer, Y.; Depezay, J. C. Tetrahedron Lett. 1995,
36, 6443-46.
(21) Spartan 02, Wavefunction Inc., Irvine, CA.
668 J. Org. Chem., Vol. 70, No. 2, 2005